ASR-3001

ASR-3001
Clinical data
Other namesASR3001; 5-MeO-iPALT; 5-MeO-ALiPT; 5-Methoxy-N-isopropyl-N-allyltryptamine; 5-Methoxy-N-allyl-N-isopropyltryptamine
Routes of
administration		Oral
Drug classSerotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Legal status
Legal status
  • In general Unscheduled
Pharmacokinetic data
Onset of action≤15 minutes (as fast as 6–8 minutes)
Duration of action1.5–2.5 hours
Identifiers
  • N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-prop-2-enylpropan-2-amine
PubChem CID
Chemical and physical data
FormulaC17H24N2O
Molar mass272.392 g·mol−1
3D model (JSmol)
  • CC(C)N(CCC1=CNC2=C1C=C(C=C2)OC)CC=C
  • InChI=1S/C17H24N2O/c1-5-9-19(13(2)3)10-8-14-12-18-17-7-6-15(20-4)11-16(14)17/h5-7,11-13,18H,1,8-10H2,2-4H3
  • Key:MRWWDVFDOFUYKB-UHFFFAOYSA-N

ASR-3001, also known as 5-methoxy-N-isopropyl-N-allyltryptamine (5-MeO-iPALT), is a serotonin receptor agonist and serotonergic psychedelic of the tryptamine and 5-methoxytryptamine families which is under development for the treatment of psychiatric disorders. It is a close analogue of related psychedelic tryptamines like 5-MeO-DALT, 5-MeO-DiPT, and 5-MeO-MiPT. The drug is taken orally.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.